Botulinum Toxin A in Patients With Myofascial Pain Syndrome With and Without Zinc Supplementation

NCT05605886 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Myofacial Pain Syndrome
Botulinum Toxin

Interventions

DRUG: Solvazinc 50mg
DRUG: placebo

Sponsor

Cairo University